Abstract
We compared the response to protease inhibitor-containing highly active antiretroviral therapy in 175 HIV-1 treatment-naive patients harbouring subtype B versus non-B. No difference in the proportion of patients with viral loads below 400 copies/ml was observed at month 24. However, there was a significant difference in the median CD4 cell increase at month 24. Whether this is caused by viral or immune factors warrants further investigation.
Original language | English |
---|---|
Pages (from-to) | 2330-2331 |
Number of pages | 2 |
Journal | AIDS |
Volume | 18 |
Issue number | 17 |
DOIs | |
Publication status | Published - 19 Nov 2004 |
Externally published | Yes |